NPM1 and acute myeloid leukemia: FLT3–ITD mutated AML displays heterogeneity, which can be attributed to variations in ITD length, insertion site, mutant-to-wild type allele ratio (AR), overall karyotype, and co-occurring mutations, particularly NPM1 [45].